We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Tesco Max All-In-One Chesty Cough & Cold Lemon Sachets used for the relief of cold and flu symptoms is being recalled
The Medicines and Healthcare products Regulatory Agency (MHRA) is advising anyone experiencing skin redness or burning sensations after they have stopped using these creams or ointments to seek advice from their health profe…
Patients should not stop any treatments without consulting their doctor or pharmacist.
Patients should not stop any treatments without consulting their doctor or pharmacist
This work will help ensure the safety of medicines and devices that reach the UK public and health service.
Batch Number 1K10121 has been found to potentially have the wrong amount of active ingredients
The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given to people who are at higher risk of specific types of blood clots because of their medical condition.
Following suspensions by some countries of the COVID-19 Vaccine AstraZeneca over suspected blood clots, the MHRA confirms that the benefits of the vaccine in preventing COVID-19 far outweigh the risks. People should still go…
Data published from UK’s independent medicines regulator confirms approved vaccines meet strict regulatory standards for safety
Women using modafinil are being warned of an increased risk of birth defects associated with modafinil use during pregnancy.
First published during the 2019 to 2022 Johnson Conservative government
The Yellow Card scheme is the UK’s system for reporting suspected side effects to medicines and adverse events with medical devices run by the Medicines and Healthcare products Regulatory Agency (MHRA).
Stronger warnings about the risk of dependence and addiction to be added to the patient information leaflet and discussed with patients
The MHRA will now issue all safety-critical alerts for medicines and medical devices that require action as National Patient Safety Alerts
People who take stimulant laxatives for constipation are being advised that these will now be sold in smaller packs, with on-pack warnings.
Warning that thermal cameras and other such “temperature screening” products, some of which make direct claims to screen for COVID-19, are not a reliable way to detect if people have the virus.
Allergy patients who carry Emerade 500 microgram adrenaline auto-injector pens should contact their prescriber and seek replacement pens of a different brand.
Patients are urged to stop taking 5mg ulipristal acetate as soon as possible and contact a healthcare professional for advice on alternative treatments.
The Medicines and Healthcare products Regulatory Agency (MHRA) launches a week long social media campaign to raise awareness about the importance of reporting suspected side effects using the Yellow Card Scheme.
MHRA update on metformin medicines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).